Alto Neuroscience, Inc. (ANRO) Misses Q3 EPS by 6c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
• PayPal (PYPL) call put ratio 2 calls to 1 put with a focus on August 28 weekly 62, 63 and 64 calls
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56